trb chemedia internat. sa
TRB Chemedica is active in the field of ophthalmology and rheumatology. TRB’s role in medicinal products is that of a pharmaceutical entrepreneur and marketing authorization holder. TRB has been assigned the task of certifying and manufacturing medical device for the group of 18 subsidiaries worldwide. The dossiers for medical devices here include preclinical data, manufacturing instructions, validation reports, usability, stability, and vigilance reports, as well as other safety data, benchmarking tests, and clinical reports.
TRB is also a pioneer in hyaluronic acid (HA) for ophthalmic and orthopedic use. The first company to introduce fermentative HA in Germany and the first company passing into MDR for intraarticular HA.
TRB Chemedica will:
participate and contribute to the research, innovation, and training activities planned in the project
host 2 secondments with 4 weeks duration each
provide training within sectors of “standard research and gap analysis” and “co-ordination of pre-clinical tests”